Skinvisible, Inc. (SKVI)
| Market Cap | 308,708 |
| Revenue (ttm) | 275,556 |
| Net Income (ttm) | -1.45M |
| Shares Out | 4.54M |
| EPS (ttm) | -0.32 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | May 7 |
| Last Price | $0.0660 |
| Previous Close | $0.0840 |
| Change ($) | -0.0180 |
| Change (%) | -21.43% |
| Day's Open | 0.0660 |
| Day's Range | 0.0660 - 0.0660 |
| Day's Volume | 14,321 |
| 52-Week Range | 0.0160 - 0.2680 |
News
There are no news available yet.
About SKVI
Skinvisible, Inc., together with its subsidiaries, focuses on the development, manufacture, and sale of topical, transdermal, and mucosal polymer-based delivery system technologies and formulations for use in pharmaceutical, over-the-counter, personal skincare, and cosmetic arenas. Its non-dermatological formulations offer solutions for women's health, pain management, and others markets. The company offers sunless tanning and sunscreen products. Skinvisible, Inc. also licenses its products to manufacturers and marketers of brands international... [Read more...]
| Industry Household & Personal Products | IPO Date Jan 7, 1999 |
| Stock Exchange OTCMKTS | Ticker Symbol SKVI |
Financial Performance
In 2020, Skinvisible's revenue was $275,556, an increase of 538.36% compared to the previous year's $43,166. Losses were -$1.45 million, -14.95% less than in 2019.